TrialOncoimmunology2020

Efficacy and biomarker analysis of CD133-directed CAR T cells in advanced hepatocellular carcinoma: a single-arm, open-label, phase II trial.

Hanren Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.